Abbott Laboratories buy Barclays PLC
Start price
26.01.24
/
50%
€103.14
Target price
26.01.25
€129.82
Performance (%)
-4.11%
Price
03.05.24
€98.38
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction for Abbott Laboratories by Barclays_PLC is down slightly. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 26.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.090% | -2.090% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Barclays PLC from $133.00 to $141.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.82
22.04.24
22.04.24
€131.54
22.04.25
22.04.25
-2.42%
03.05.24
03.05.24
